Related Experiment Video
Updated: Jun 6, 2026
13:47
Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis
Published on: June 3, 2018
Cost-effectiveness of screening for open angle glaucoma in developed countries
1Department of Ophthalmology, University of Oulu and Tampere University Hospital, Finland. anja.tuulonen@pshp.fi
Indian Journal of Ophthalmology
|December 15, 2010
Summary
Glaucoma care in developed nations needs improvement due to rising costs and service strain. Current evidence is insufficient to determine if population screening is cost-effective for managing glaucoma.
Area of Science:
- Ophthalmology and Health Economics
- Public Health and Healthcare Management
Background:
- Developed countries face escalating healthcare costs, straining glaucoma services.
- Current glaucoma care exhibits issues with both under- and over-diagnosis and treatment.
- Finite healthcare resources necessitate strategic allocation for optimal eye health outcomes.
Purpose of the Study:
- To reappraise current glaucoma management strategies in light of service performance and costs.
- To review economic evaluation methods and cost-effectiveness evidence for systematic glaucoma screening.
- To identify needs for future research and behavioral changes in glaucoma care.
Main Methods:
- Overview of economic evaluation methodologies.
- Synthesis of existing evidence on the cost-effectiveness of systematic glaucoma screening in developed countries.
- Analysis of challenges in evaluating economic literature and promoting evidence-based behavioral change.
Main Results:
- The current performance of glaucoma services presents opportunities for improved diagnosis and treatment.
- Limited evidence exists to support the cost-effectiveness of systematic population screening for glaucoma.
- Prioritization of interventions, including case finding, is essential due to resource constraints.
Conclusions:
- Glaucoma management strategies require reappraisal to address cost and service burdens.
- More research is needed to determine the cost-effectiveness of systematic glaucoma screening.
- Evidence-based prioritization and behavioral changes are crucial for efficient glaucoma care.
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:25Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...